16.1 In Practice: Responding to an Infectious Disease Outbreak amid a Humanitarian Emergency

Author:

Ross Elizabeth,Rasinski Emily,Han Carol,Paganini Francesco

Abstract

AbstractThis chapter highlights the work and leadership of the United States Agency for International Development (USAID) Bureau for Humanitarian Assistance (BHA) and its humanitarian partners to respond to humanitarian needs that arise from international health emergencies. To accomplish these tasks, aid workers strive to learn from the challenges and successes of the immediate past: the 2010 cholera outbreak that ravaged Haitian communities reeling from a catastrophic earthquake; the 2014 West Africa Ebola epidemic that required a multisectoral, multinational global response in three countries; the 2018 Ebola “Outbreak 10” in the Democratic Republic of the Congo (DRC) during an ongoing, multifaceted humanitarian crisis; and the 2020 coronavirus disease 2019 (COVID-19) pandemic that further complicated the DRC Ebola outbreak response (aside from its historic global effects). While learning from these humanitarian crises, response workers actively plan for an uncertain future in which populations everywhere—most acutely in disaster-prone countries with the fewest resources—face climate change and environmental degradation pressures likely to make infectious disease outbreaks more frequent globally in decades to come.

Publisher

Springer International Publishing

Reference19 articles.

1. Caron A, Bourgarel M, Cappelle J, Liégeois F, De Nys H, Roger F. Ebola virus maintenance: if not (only) bats, what else? Viruses. 2018. https://doi.org/10.3390/v10100549.

2. Crawford N, Holloway K. The Democratic Republic of Congo’s 10th Ebola response: lessons on international leadership and coordination. London: Overseas Development Institute. Institute OD; 2021.

3. FDA. ERVEBO. 2019a. https://www.fda.gov/vaccines-blood-biologics/ervebo. Accessed 17 Oct 2021.

4. FDA. First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response. Washington, DC: U.S. Food and Drug Administration; 2019b.

5. FDA. FDA approves first treatment for Ebola virus. Washington, DC: U.S. Food and Drug Administration; 2020a.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3